Clinical Trial Update: Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

View source ↗

Summary

Clinical trial update investigating predictive determinants of nephrotic syndrome remission in patients with at-risk APOL1 polymorphisms, including APOL1-associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Apol1-associated Kidney Disease
• Focal Segmental Glomerulosclerosis
• Nephrotic Syndrome

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Nephrotic Syndrome, Focal Segmental Glomerulosclerosis | Status: NOT_YET_RECRUITING